Melanoma-associated antigen C1 (450-458)

Melanoma-associated antigen C1 (450-458) is a synthetic peptide fragment derived from the MAGE-C1 protein, a member of the melanoma antigen gene family known for its restricted expression in various tumor cells, particularly melanomas, and limited presence in normal tissues. As a defined peptide epitope corresponding to amino acids 450 through 458 of the parent MAGE-C1 sequence, it serves as a valuable molecular tool in immunological, oncological, and biochemical research. The specific sequence is recognized for its role in antigen presentation and immune recognition processes, making it highly relevant for studies focused on tumor immunology, antigen processing, and peptide-MHC interactions. Its biochemical properties and defined sequence enable precise experimental manipulations in both cellular and molecular assays.

Immunological assay development: The peptide is widely utilized in the design and optimization of immunoassays, such as ELISPOT, flow cytometry-based tetramer staining, and T cell activation assays. By serving as a defined antigenic epitope, it enables researchers to evaluate the presence, frequency, and functional status of MAGE-C1-specific cytotoxic T lymphocytes in various biological samples. This application is particularly important for elucidating immune responses against tumor-associated antigens and for benchmarking the immunogenicity of candidate peptides in preclinical research.

Epitope mapping and T cell specificity studies: As a well-characterized peptide segment, Melanoma-associated antigen C1 (450-458) is instrumental in mapping T cell epitopes and determining MHC class I binding preferences. Researchers employ it to identify and characterize the specificity of T cell receptors recognizing MAGE-C1-derived peptides, thereby gaining insights into the determinants of antigen recognition and the diversity of the T cell repertoire in tumor immunity. Such studies inform the rational design of peptide-based immunogens and enhance understanding of antigen processing pathways.

Antigen processing and presentation research: The defined sequence of this peptide supports investigations into the mechanisms of antigen processing, transport, and presentation by major histocompatibility complex (MHC) molecules. By introducing the peptide into antigen-presenting cells or in vitro binding assays, researchers can dissect the molecular interactions governing peptide loading onto MHC class I molecules and the subsequent recognition by CD8+ T cells. These studies are critical for advancing knowledge of immune surveillance and the molecular basis of tumor escape mechanisms.

Peptide-based vaccine candidate evaluation: In preclinical research, the peptide serves as a model antigen to assess the immunogenic potential of MAGE-C1-derived sequences for cancer vaccine development. It is used to stimulate immune cells in vitro, enabling the evaluation of cytokine production, cytotoxic activity, and memory T cell responses. Data generated from such studies guide the selection and optimization of peptide epitopes for inclusion in next-generation cancer vaccine constructs, supporting translational research efforts in tumor immunotherapy.

Analytical and quality control reference: Owing to its defined sequence and immunological relevance, the peptide is often employed as a reference standard in analytical techniques such as mass spectrometry, high-performance liquid chromatography (HPLC), and peptide quantification assays. Its use as a standard supports method validation, calibration, and quality control in laboratories engaged in peptide synthesis, immunology, and proteomics research, ensuring the reliability and reproducibility of experimental results.

1. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes

2. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

3. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide